Abstract:Angiogenesis is closely coupled with osteogenesis and has equal importance. Thus, promoting angiogenesis during the bone repair process is vital for ideal bone regeneration. As important mediators of cell-cell communication and biological homeostasis, mesenchymal stem cell-derived small extracellular vesicles (MSC-sEVs) have been proved to be highly involved in bone and vascular regeneration. Because hypoxia microenvironment promotes the proangiogenic activity of MSCs, in the present study, we investigate the effect and underlying molecular mechanisms of sEVs from hypoxia-preconditioned MSCs (hypo-sEVs) on angiogenesis and develop an effective strategy to promote vascularized bone regeneration. Compared to sEVs from normoxia MSCs (nor-sEVs), hypo-sEVs promoted the proliferation, migration, and angiogenesis of HUVECs and ultimately enhanced bone regeneration and new blood vessel reconstruction in a critical-size calvarial bone defect model. miRNA sequence and the verified results showed that miR-210-3p in hypo-sEVs was increased via HIF-1α under hypoxia. The upregulated miR-210-3p in hypo-sEVs promoted angiogenesis by downregulating EFNA3 expression and enhancing the phosphorylation of the PI3K/AKT pathway. Thus, this study suggests a successful strategy to enhance vascularized bone regeneration by utilizing hypo-sEVs via the miR-210-3p/EFNA3/PI3K/AKT pathway. STATEMENT OF SIGNIFICANCE: Considering the significance of vascularization in ideal bone regeneration, strategies to promote angiogenesis during bone repair are required. Hypoxia microenvironment can promote the proangiogenic potential of mesenchymal stem cells (MSCs). Nonetheless, the therapeutic effect of small extracellular vesicles (sEVs) from hypoxia-preconditioned MSCs on cranio-maxillofacial bone defect remains unknown, and the underlying mechanism is poorly understood. This study shows that hypo-sEVs significantly enhance the proliferation, migration, and angiogenesis of HUVECs as well as promote vascularized bone formation. Moreover, this work indicates that HIF-1α can induce overexpression of miR-210-3p under hypoxia, and miR-210-3p can hinder EFNA3 expression and subsequently activate the PI3K/AKT pathway. The application of hypo-sEVs provides a facile and promising strategy to promote vascularized bone regeneration in a critical-size bone defect model.

Repair of Critical-Sized Rat Calvarial Defects Using Genetically Engineered Bone Marrow-Derived Mesenchymal Stem Cells Overexpressing Hypoxia-Inducible Factor-1Α.

Repairing Critical-Sized Calvarial Defects with BMSCs Modified by a Constitutively Active Form of Hypoxia-Inducible Factor-1Α and a Phosphate Cement Scaffold.

BMSC-Exosomes Carry Mutant HIF-1α for Improving Angiogenesis and Osteogenesis in Critical-Sized Calvarial Defects

Blood vessel formation in the tissue-engineered bone with the constitutively active form of HIF-1α mediated BMSCs.

Epigenetically Modified Bone Marrow Stromal Cells in Silk Scaffolds Promote Craniofacial Bone Repair and Wound Healing

Transplantation of Hypoxia Preconditioned Bone Marrow Mesenchymal Stem Cells Enhances Angiogenesis and Neurogenesis after Cerebral Ischemia in Rats.

Repair of critical-sized bone defects with anti-miR-31-expressing bone marrow stromal stem cells and poly(glycerol sebacate) scaffolds

The bone-forming effects of HIF-1α-transduced BMSCs promote osseointegration with dental implant in canine mandible

Mobilizing Endogenous Progenitor Cells Using pSDF1α‐Activated Scaffolds Accelerates Angiogenesis and Bone Repair in Critical‐Sized Bone Defects

In Vitro Study of Enhanced Osteogenesis Induced by HIF-1α-transduced Bone Marrow Stem Cells

Exosomes Secreted by Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Repair Critical-Sized Bone Defects through Enhanced Angiogenesis and Osteogenesis in Osteoporotic Rats

Wnt10b-overexpressing umbilical cord mesenchymal stem cells promote critical size rat calvarial defect healing by enhanced osteogenesis and VEGF-mediated angiogenesis

Vascular restoration through local delivery of angiogenic factors stimulates bone regeneration in critical size defects

The Healing of Critical-Size Calvarial Bone Defects in Rat with Rhpdgf-Bb, BMSCs, and Β-Tcp Scaffolds.

Enhancement of Bone Formation by Genetically-Engineered Bone Marrow Stromal Cells Expressing BMP-2, VEGF and Angiopoietin-1.

Reconstruction of Rat Calvarial Defects with Human Mesenchymal Stem Cells and Osteoblast-Like Cells in Poly-Lactic-co-glycolic Acid Scaffolds

Small Extracellular Vesicles Derived from Hypoxic Mesenchymal Stem Cells Promote Vascularized Bone Regeneration Through the Mir-210-3p/efna3/pi3k Pathway

Smurf1-targeting miR-19b-3p-modified BMSCs combined PLLA composite scaffold to enhance osteogenic activity and treat critical-sized bone defects

Coculture of Peripheral Blood CD34+ Cell and Mesenchymal Stem Cell Sheets Increase the Formation of Bone in Calvarial Critical-Size Defects in Rabbits.

Activation of the Hypoxia-Inducible Factor-1 Alpha Pathway Accelerates Bone Regeneration

LvBMP-2 Gene-Modified BMSCs Combined with Calcium Phosphate Cement Scaffolds for the Repair of Calvarial Defects in Rats